Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.17197
Abstract: yet to recover to the pre-COVID-19 levels. Maintaining capacity to treat patients with high-risk haematological malignancies is essential requiring adherence to guidelines designed to reduce the spread of infection and create a safe environment for… read more here.
Keywords: cell lymphoma; outcomes management; patients mantle; mantle cell ... See more keywords
Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17366
Abstract: We characterised patients with mantle cell lymphoma (MCL) with poor prognosis based on differences in immune infiltration. Different expressions of the tumour cell markers Cyclin D1 and sex‐determining region Y‐box transcription factor 11 (SOX11), and… read more here.
Keywords: lymphoma; patients mantle; independent established; cd163 ... See more keywords
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of haematology"
DOI: 10.1111/ejh.13985
Abstract: BACKGROUND Long-term clinical and molecular remissions in patients with mantle cell lymphoma (MCL) after autologous stem cell transplantation (ASCT) have been evaluated in only a few studies. DESIGN AND METHODS Sixty-five patients with MCL received… read more here.
Keywords: long term; line asct; mantle cell; line ... See more keywords
Gastrointestinal Involvement in Patients with Mantle Cell Lymphoma: A Single Center Experience of Eighty-Five Patients
Sign Up to like & getrecommendations! Published in 2019 at "Digestive Diseases"
DOI: 10.1159/000496508
Abstract: Background: The frequency of endoscopically apparent gastrointestinal tract (GI) involvement in patients with mantle cell lymphoma (MCL) at diagnosis is thought to be in the range of 30%. While reports on GI involvement in MCL… read more here.
Keywords: mcl; single center; patients mantle; involvement patients ... See more keywords
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007241
Abstract: Key Points • Patients with mantle cell lymphoma have higher relative risks of respiratory, blood, and infectious disease compared with healthy comparators.• Late effects varied very little by treatment with or without transplantation. read more here.
Keywords: effects patients; late effects; cell lymphoma; transplantation ... See more keywords
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2021.279561
Abstract: Rituximab maintenance (RM) after autologous stem cell transplantation (ASCT) is standard-of-care for young patients with mantle cell lymphoma (MCL). RM may enhance post-transplantation immune depression and risk of infections. We compared infection incidence and immune… read more here.
Keywords: cell; stem cell; cell transplantation; transplantation ... See more keywords